Macquarie Group’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-221,651
| Closed | -$1.84M | – | 1699 |
|
|
2024
Q3 | $1.84M | Sell |
221,651
-228,420
| -51% | -$1.9M | ﹤0.01% | 1252 |
|
|
2024
Q2 | $3.22M | Buy |
450,071
+171,009
| +61% | +$1.22M | ﹤0.01% | 1088 |
|
|
2024
Q1 | $2.42M | Buy |
+279,062
| New | +$2.42M | ﹤0.01% | 1166 |
|
|
2023
Q2 | – | Sell |
-101,896
| Closed | -$1.43M | – | 1701 |
|
|
2023
Q1 | $1.43M | Hold |
101,896
| – | – | ﹤0.01% | 1270 |
|
|
2022
Q4 | $1.46M | Sell |
101,896
-64,411
| -39% | -$922K | ﹤0.01% | 1303 |
|
|
2022
Q3 | $4.27M | Buy |
166,307
+16,219
| +11% | +$417K | 0.01% | 1030 |
|
|
2022
Q2 | $4.26M | Buy |
150,088
+22,075
| +17% | +$627K | ﹤0.01% | 1072 |
|
|
2022
Q1 | $4.52K | Sell |
128,013
-81,735
| -39% | -$2.88K | ﹤0.01% | 1141 |
|
|
2021
Q4 | $8.79M | Buy |
209,748
+61,478
| +41% | +$2.58M | 0.01% | 970 |
|
|
2021
Q3 | $7.28M | Sell |
148,270
-117,518
| -44% | -$5.77M | 0.01% | 1002 |
|
|
2021
Q2 | $11.1M | Buy |
+265,788
| New | +$11.1M | 0.01% | 912 |
|